These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23681193)

  • 21. Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.
    Johnson SM; Murphy RC; Geiger JA; DeRocher AE; Zhang Z; Ojo KK; Larson ET; Perera BG; Dale EJ; He P; Reid MC; Fox AM; Mueller NR; Merritt EA; Fan E; Parsons M; Van Voorhis WC; Maly DJ
    J Med Chem; 2012 Mar; 55(5):2416-26. PubMed ID: 22320388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapeutics for
    Wu RZ; Zhou HY; Song JF; Xia QH; Hu W; Mou XD; Li X
    J Med Chem; 2021 Dec; 64(24):17627-17655. PubMed ID: 34894691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis.
    Dos Santos DA; Souza HFS; Silber AM; de Souza TACB; Ávila AR
    Front Cell Infect Microbiol; 2023; 13():1175409. PubMed ID: 37287468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of mitogen-activated protein kinase 1 inhibits development and growth of Toxoplasma gondii.
    Cao L; Wang Z; Wang S; Li J; Wang X; Wei F; Liu Q
    Parasitol Res; 2016 Feb; 115(2):797-805. PubMed ID: 26526952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents
    Débare H; Moiré N; Baron F; Lantier L; Héraut B; Van Langendonck N; Denevault-Sabourin C; Dimier-Poisson I; Debierre-Grockiego F
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antibacterials for the treatment of toxoplasmosis; a patent review.
    Rodriguez JB; Szajnman SH
    Expert Opin Ther Pat; 2012 Mar; 22(3):311-33. PubMed ID: 22404108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.
    Zhang Z; Ojo KK; Johnson SM; Larson ET; He P; Geiger JA; Castellanos-Gonzalez A; White AC; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5264-7. PubMed ID: 22795629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
    Doggett JS; Ojo KK; Fan E; Maly DJ; Van Voorhis WC
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3547-9. PubMed ID: 24687502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for small molecule inhibitors of Toxoplasma gondii.
    Kortagere S
    Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic interactions between
    Blume M; Seeber F
    F1000Res; 2018; 7():. PubMed ID: 30467519
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.
    Wei S; Daniel BJ; Brumlik MJ; Burow ME; Zou W; Khan IA; Wadsworth S; Siekierka J; Curiel TJ
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4324-8. PubMed ID: 17923491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
    Kortagere S; Mui E; McLeod R; Welsh WJ
    J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoplasma and Plasmodium protein kinases: roles in invasion and host cell remodelling.
    Lim DC; Cooke BM; Doerig C; Saeij JP
    Int J Parasitol; 2012 Jan; 42(1):21-32. PubMed ID: 22154850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted overexpression of cyclic AMP-dependent protein kinase subunit in Toxoplasma gondii promotes replication and virulence in host cells.
    Sun H; Wang S; Zhao X; Yao C; Zhuang H; Huang Y; Chen X; Yang Y; Du A
    Vet Parasitol; 2017 Aug; 243():248-255. PubMed ID: 28807302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
    Wei S; Marches F; Daniel B; Sonda S; Heidenreich K; Curiel T
    Int J Parasitol; 2002 Jul; 32(8):969-77. PubMed ID: 12076626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An updated review of chemical compounds with anti-Toxoplasma gondii activity.
    Rodriguez JB; Szajnman SH
    Eur J Med Chem; 2023 Dec; 262():115885. PubMed ID: 37871407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and evolutionary adaptation of rhoptry kinases and pseudokinases, a family of coccidian virulence factors.
    Talevich E; Kannan N
    BMC Evol Biol; 2013 Jun; 13():117. PubMed ID: 23742205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma.
    Lourido S; Shuman J; Zhang C; Shokat KM; Hui R; Sibley LD
    Nature; 2010 May; 465(7296):359-62. PubMed ID: 20485436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Toxoplasma gondii calcium-dependent protein kinase 7 is involved in early steps of parasite division and is crucial for parasite survival.
    Morlon-Guyot J; Berry L; Chen CT; Gubbels MJ; Lebrun M; Daher W
    Cell Microbiol; 2014 Jan; 16(1):95-114. PubMed ID: 24011186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.